For patients whose cancer has returned, First Ascent Biomedical provides new ways to fight by combining functional drug testing, genomics, and artificial intelligence to design an individualized treatment plan in a week for each patient. Our technology rapidly grows tumor bulk, more importantly chemo-resistant cells enabling the testing 100s of FDA-approved drugs to measure the cellular response of both cell populations. This is the key dataset for the AI engine, supported by genomics data to identify every cancer weakness and identify which drugs work.
To Learn More-
Contact us at: info@firstascentbio.com
Or go to: www.FirstAscentBio.com
Company Details
- Employees
- 12
- Founded
- -
- Address
- 1421 Sw 107th Ave,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Cancer Research, Cancer Treatment, Precision Therapy, DNA Sequencing, RNA Sequencing, Functional Defined Therapy, Phenotype Screening, Personalized Pharmacogenomics, Targeted Therapy, Personalized Therapy, Artificial Intelligence, drug development, Biomarker development, Biomarker validation, Biotechnology, Precision Medicine, Healthcare, Personalized Medicine, AI, Functional Precision Medicine.
- HQ
- Miami, Florida
First Ascent Biomedical Questions
First Ascent Biomedical's website is https://firstascentbiomedical.com
First Ascent Biomedical's LinkedIn profile is https://www.linkedin.com/company/firstascentbio
First Ascent Biomedical has
12 employees.
View email and phone details for 12
employees at First Ascent Biomedical.
First Ascent Biomedical's industry is
Biotechnology Research
First Ascent Biomedical's top competitors are
Cancerx,
Cdr Labs,
Encapsulate,
Jome,
Dfns,
Phoenix Tailings,
Qusecure,
Azoma,
Pbr Life Sciences (Techstars '23),
Parambil.
First Ascent Biomedical's categories are Biotechnology Research
First Ascent Biomedical's founding year is 2018
